Drug Information

Drug General Information
Drug ID
D0D5SP
Former ID
DNC013885
Drug Name
Semiplenamide G
Drug Type
Small molecular drug
Indication Discovery agent Investigative [526859]
Formula
C24H45NO4
Canonical SMILES
CCCCCCCCCCCCCCCC1C(O1)(C)C(=O)NC(C)COC(=O)C
InChI
1S/C24H45NO4/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-22-24(4,29-22)23(27)25-20(2)19-28-21(3)26/h20,22H,5-19H2,1-4H3,(H,25,27)/t20?,22-,24+/m1/s1
InChIKey
MILXVDLKZSMGBO-ZUBLCLOHSA-N
PubChem Compound ID
21589501
Target and Pathway
Target(s) Cannabinoid receptor 1 Target Info Inhibitor [526859]
KEGG Pathway Rap1 signaling pathway
Neuroactive ligand-receptor interaction
Retrograde endocannabinoid signaling
PANTHER Pathway Endogenous cannabinoid signaling
Pathway Interaction Database N-cadherin signaling events
Reactome Class A/1 (Rhodopsin-like receptors)
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Small Ligand GPCRs
BDNF signaling pathway
GPCR ligand binding
GPCR downstream signaling
GPCRs, Other
References
Ref 526859J Nat Prod. 2003 Oct;66(10):1364-8.Semiplenamides A-G, fatty acid amides from a Papua New Guinea collection of the marine cyanobacterium Lyngbya semiplena.
Ref 526859J Nat Prod. 2003 Oct;66(10):1364-8.Semiplenamides A-G, fatty acid amides from a Papua New Guinea collection of the marine cyanobacterium Lyngbya semiplena.